Tesofensine A Summary:修订历史

跳转到导航 跳转到搜索

差异选择:选中要对比的版本的单选按钮,按Enter键或下方的按钮。
说明:(当前)=与最后版本之间的差异,(之前)=与上一版本之间的差异,=小编辑。

2024年10月29日 (星期二)

  • 当前之前 06:122024年10月29日 (二) 06:12MaricruzMeece4 留言 贡献 8,315字节 +8,315 创建页面,内容为“Tesofensine is a several monoamine-reuptake prevention decreasing the reuptake of norepinephrine, serotonin, and dopamine. In preclinical tests, the medication was revealed to be risk-free in pet versions and to generate weight-loss during scientific tests in people who had Parkinson's disease or Alzheimer's illness. Acarbose generates minute weight reduction in a few experiments among fully grown individuals (0.46 kg weight management vs 0.33 kg weight gain wi…”